Catalent, through its wholly owned subsidiary, Catalent Pharma Solutions, has agreed, to acquire Pharmatek Laboratories, a contract development and manufacturing organization based in San Diego, California. Financial details were not disclosed

Founded in 1999, Pharmatek provides dosage form development and clinical-scale cGMP manufacturing of oral, injectable, and topical products for more than 100 customers globally. Pharmatek’s site in San Diego is a cGMP facility that employs nearly 200 people Pharmatek provides development and analytical services for more than 120 molecules annually, and its facility comprises 68,000 square feet of laboratory, manufacturing,and support space, with two analytical labs, two formulation labs, four engineering rooms and nine certified ISO Class 8 manufacturing suites. The site also features 18,000 square feet of laboratory, manufacturing, and support space dedicated to development and manufacturing of highly potent compounds.

The transaction is subject to customary closing conditions and is expected to close in the next few weeks.

Source: Catalent